HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Centrally induced hypotension and bradycardia after administration of alpha-methylnoradrenaline into the area of the nucleus tractus solitarii of the rat.

Abstract
1 In anaesthetized rats, bilateral injections of alpha-methylnoradrenaline, noradrenaline or adrenaline into the area of the nucleus tractus solitarii (NTS) of the brain stem caused dose-dependent decreases of systemic arterial blood pressure and heart rate. The effects of alpha-methylnoradrenaline were most pronounced and lasted longest. 2 The cardiovascular effects of alpha-methylnoradrenaline appeared to be restricted to the medio-caudal part of the NTS. 3 Prior administration of the alpha-adrenoceptor blocking agent, phentolamine, reversed the fall in blood pressure and heart rate induced by alpha-methylnoradrenaline into an increase. 4 Systemic administration of atropine combined with vagotomy potentiated the inhibitory effects of alpha-methylnoradrenaline on the cardiovascular system.
AuthorsW De Jong, F P Nijkamp
JournalBritish journal of pharmacology (Br J Pharmacol) Vol. 58 Issue 4 Pg. 593-8 (Dec 1976) ISSN: 0007-1188 [Print] ENGLAND
PMID793669 (Publication Type: Journal Article)
Chemical References
  • Atropine
  • Nordefrin
  • Norepinephrine
  • Epinephrine
  • Phentolamine
Topics
  • Animals
  • Atropine (pharmacology)
  • Blood Pressure (drug effects)
  • Epinephrine (pharmacology)
  • Heart Rate (drug effects)
  • Injections
  • Male
  • Medulla Oblongata
  • Nordefrin (administration & dosage, pharmacology)
  • Norepinephrine (analogs & derivatives, pharmacology)
  • Phentolamine (pharmacology)
  • Rats
  • Time Factors
  • Vagus Nerve (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: